Published in Drug Week, October 17th, 2003
The model moves swiftly through AD, starting with the onset of AD symptoms and finishing with Alzheimer-like memory loss, in 4 weeks.
New techniques and methodologies to produce animal models provide researchers with ways to more efficiently study human disease, and the therapeutics that hold promise for those diseases. The use of engineered animal models to explore the selection of appropriate drug targets holds great promise...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.